Mentor Capital Inc. is a public operating company that provides mezzanine financing to leaders in the cannabis space. Through our spinoff program, we provide a low-cost option for companies trying to enter the public market. Additionally, we provide liquidity and support to ensure the organization is ready for that transition. All the while leaving operating control in the hands of the founders.
Because adult social use and medical marijuana opportunities often overlap, Mentor Capital participates in the legal recreational marijuana market. However, Mentor’s preferred focus is medical and the company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing intraocular pressures from glaucoma and blunting chronic pain.
Mentor seeks to deliver a higher price to founders for a smaller slice of their business. Retaining control, receiving greater liquidity and working with a square corner organization are three key advantages to cannabis founders working with Mentor Capital, Inc.
Mentor Capital migrated to the cannabis space from leading-edge cancer investments when government actions collapsed the new leading cancer sector (e.g. Dendreon, the market leader, dropped from $44 per share to $2.90 per share.) Mentor still retains only minor cancer-related investments but all new investments are now in the cannabis space.
Originally, Mentor Capital was formed in Silicon Valley in 1985 with $1,000 by current CEO, Chet Billingsley. The company completed dozens of early private acquisitions and went public in 1996.
Mentor Capital feels there is significant opportunity to approach the medical marijuana market as a business-focused, high-integrity, public company providing significantly more financing to private cannabis companies. As a result, Mentor will be able to return increasing stock value to the investing public.
Leaders in the cannabis space who are thinking of going public or seeking the advantages of the public market, including greater ease of funding, liquidity, a pathway for investor exit, plus the availability of acquisition currency are encouraged to contact Mentor Capital to discuss how they might capture those public benefits by working through MNTR.